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Congenital radioulnar synostosis (RUS) is a rare developmental abnormality involving fusion 
of the bones of the forearms (radius and ulna) preventing normal supination of the affected 
forearm and has been recognized in the orthopaedic literature since the mid-1800s. It is 
apparent that there is a subgroup of patients with RUS who also present with hematological 
abnormalities ranging from thrombocytopenia to myelodysplastic syndrome (MDS). Here we 
report on a series of seven families with RUS and diverse hematological defects ranging 
from single cytopenias to global bone marrow failure (BMF); some individuals had severe 
BMF in childhood whilst others only a modest single cytopenia well into adulthood. We 
identify three different germline variants (two novel) in the MDS1 and EVI1 complex locus 
(MECOM) in five of the families. The other two families remain uncharacterized. We have 
further expanded the range of genotypes and phenotypes associated with RUS and 
hematological disease. 
 
RUS can occur with other abnormalities in the skeleton, heart, urinary tract, as well as 
aneuploid syndromes1. RUS also occurs as part of the inherited BMF spectrum of diseases 
and is known as radioulnar synostosis with amegakaryocytic thrombocytopenia (RUSAT). It 
is usually characterized by thrombocytopenia which progresses to pancytopenia coupled 
with a congenital fusion of the radius and ulna. Heterozygous germline variants in two genes 
have been associated with RUSAT: HOXA11 (Homeobox A11)2 (RUSAT1, MIM#605432) 
and MECOM (MDS1 and EVI1 complex locus)3 (RUSAT2, MIM#616738). HOXA11 is 
involved in upper limb development in early embryogenesis as well as normal hematopoiesis 
and leukemogensis. MECOM is essential for the proliferation of hematopoietic stem cells 
and is expressed in developing limbs4.  
 
We identified a cohort of nine cases from seven families with RUS and variable 
hematological disease. The clinical characteristics of these patients (including one we have 
previously described5) are detailed in Table 1. Radiographs of the radius and ulna fusions 
from families 4-6 (Figure 1), show all cases have a very similar radiological appearance. 
Using Sanger sequencing, we screened the coding exons of HOXA11 and MECOM in the 
index cases of these families. No coding variants were identified in HOXA11. However we 
did identify coding variants in MECOM (NM_001105078) in seven individuals from five 
families. Families 1-3 shared the same variant (c.2248C>T; p.Arg750Trp: Figure 2A) as 
reported by Niihori et al3. Novel variants were identified in families 4 and 5.  These were 
c.2278G>C; p.Pro760Ala and c.2272G>A; p.Glu758Lys, respectively (Figure 2B). Based on 
genetic studies and clinical presentation an autosomal dominant inheritance pattern was 
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observed in families 1 and 5. From the information available it appears that the variants in 
families 2-4 were de novo which is in agreement with the initial report.3 After direct Sanger 
sequencing families 6 and 7 (Figure 2C) remain uncharacterized despite having a similar 
presentation, suggesting further genes may be involved in this disorder. There are three 
reports in the literature5-7 of patients presenting with pancytopenia and RUS with no 
indication of the underlying genetic cause being given, as well as a more unusual case of 
RUS associated B-cell acute lymphoblastic leukaemia8 where the BCR-ABL gene fusion is 
unlikely to explain the RUS  (Supplementary Table 1). It is unlikely that a large germline 
MECOM deletion has been missed in families 6 and 7 as reports describe two cases where 
deletions encompassing some or all of MECOM result in thrombocytopenia but not the 
associated RUS9, 10. Further studies are needed in these two families to determine the 
underlying basis of the disease. 
 
Reviewing the literature, the first disease gene to be associated with both RUS and bone 
marrow failure was HOXA11. The heterozygous variant c.872delA, p.Asn291ThrfsX3 was 
identified in six individuals from two families (Supplementary Table 1)2 and causes a 
premature truncation of HOXA11. In both families the variant was inherited from the father. 
Interestingly both fathers showed skeletal abnormalities of the arm but neither had any 
hematological disease. All the affected children presented with thrombocytopenia from birth, 
with three out of the four undergoing BMT. Recently several papers have been published 
identifying germline variants in MECOM in patients with various bone marrow failures either 
with or without the presence of RUS (Supplementary Tables 1 and 2).2, 3, 11-13 From these 
reports, together with findings of this study we are able to demonstrate that even with the 
same variant the age of onset and the severity of BMF is highly variable. We observe that 
the MECOM variant p.Arg750Trp is a recurrent change that can present with a variety of 
hematological defects in association with RUS. In five out of the six families with this variant 
(families 2 and 3 in this study, and cases described in references 3, 10, 12) the disease 
appears de novo, with presentation very early in infancy/childhood and all cases required a 
BMT. The sixth case with p.Arg750Trp (index case family 1) shows dominant inheritance 
pattern and the hematological involvement progressed from aplastic anemia to 
myelodysplastic syndrome (MDS); this presentation of RUS and development of MDS in 
adulthood is similar to the family reported by Ripperger et al12 even though the causative 
variant is different. Autosomal dominant inheritance was also seen in a second family in our 
cohort (family 5). The hematological abnormality in the affected cases from family 5 was 
variable: ranging from normal blood count, mild single cytopenia to severe pancytopenia, 
again demonstrating variability in severity and age of onset. Interestingly, there are reports of 
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seven patients with germline heterozygous variants (including two deletions) affecting 
MECOM where there is no presence of RUS but the severe associated hematological 
disease required treatment with BMT.9-11 These patients form a distinct group as they were 
sporadic, de novo cases who presented with disease in infancy. The reason behind this 
difference in phenotype is unclear at present.  
 
All the heterozygous MECOM variants reported in this study are highly conserved from 
humans to yeast (Figure 2D), cluster within 10 amino acids (aa750-760) and impact on 
either the highly conserved Cys2His2 zinc finger motif (zinc finger 8, aa733-755) or the 
adjacent linker motif (aa756-760). Preliminary data suggest levels of MECOM appear to be 
reduced in lymphoblastoid cell lines heterozygous for p.Glu758Lys (Supplementary Figure 
1). Cys2His2 zinc fingers are one of the most common DNA-binding motifs found in 
eukaryotic transcription factors and usually occur in groups allowing for multiple tandem 
contacts along the DNA. EVI1 has 2 zinc finger domains; proximal domain contains 7 motifs 
and the distal contains 3 motifs (Figure 2E) and it has been shown that these 2 domains can 
have different functions.14 Studies removing the whole of the 8th zinc finger domain have 
shown that this can block granulopoiesis confirming this region is involved in hematopoiesis.  
All germline variants identified to date in MECOM are shown in Figure 2E. It is noteworthy 
that all variants associated with the co-presentation of RUS and hematological disease 
cluster in region spanning zinc fingers 8 and 9. The variants observed in patients with 
hematological disease without RUS (verified by x-ray)11 are more widely distributed 
throughout the complex, including two deletions that either remove the MDS1 part of the 
complex or the entire gene region.9, 10 Further reports may help to clarify whether there is a 
definitive genotype-phenotype correlation for disease associated variants in MECOM. 
 
In this study we have genetically characterized patients from five out of seven families with 
RUS and hematological disease. As well as identifying novel pathogenic MECOM variants 
we show that three of the families share the same previously identified MECOM variant. The 
differences in presentation have enabled us to expand the clinical phenotype from a severe 
global bone marrow failure requiring transplantation that presents very early in infancy to a 
syndrome that presents with variable hematological disease in adults. The disease can also 
be inherited in families in a dominant manner and in these cases the hematological 
involvement is more variable both in terms of severity and age of presentation. It is also 
notable that the hematological features can be very variable, even amongst affected 
members of the same family as exemplified by families 1 and 5. Lack of variants in MECOM 
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and HOXA11 in two of the families, together with uncharacterized families in the literature, 
suggest there may be other disease genes to be identified. Also in light of the number of 
BMF cases where MECOM variants can occur independently of the development of RUS, a 
genetic screen of MECOM should be undertaken in all new patients with BMF, particularly if 
there is no family history of disease. Finally, it has become clear that RUS associated 
hematological abnormalities are frequently more global and variable, rather than being 
limited to thrombocytopenia. The description RUS associated hematological disease 
(RUSHD) is therefore perhaps more appropriate than RUS associated amegakaryocytic 
thrombocytopenia (RUSAT) which was initially coined for the disease features observed in 
patients with germline HOXA11 or MECOM variants.  
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Table 1: Characteristics of cases in this study 
FAMILY 1 2 3 4 55 55 5 6 7  
Patient Index case Index case Index case Index case IV-1 (Index case) IV-3 V-1 Index case Index case 
Age at 
diagnosis Childhood NA 16 months 6 months 11 years 13 years 7 years Birth 3 years 
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breakage test Normal  Normal Normal Normal Normal  Normal Normal 
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NA – not available; Blt – bilateral; MDS- myelodysplastic syndrome; * - this patient had aplastic anemia in childhood which resolved, then at age 37 years he 
presented with trilineage MDS (subtype: refractory cytopenia); AA-aplastic anemia; †PROVEAN (Protein Variation Effect Analyzer) is a software tool which 
















Figure 1: X-rays of the forearms showing proximal fusion of the radius and ulna 
A -Radiographs of both arms from the index case of family 4. B - Affected mother of family 5 
(generation III). C - Index case of family 6 in which neither HOXA11 nor MECOM variants 
were detected. Arrows highlight proximal fusion of the radius and ulna. 
 
Figure 2: Family trees of all cases and MECOM variants identified in this study 
A - Families 1-3 share the same heterozygous variant in MECOM.  B - Family trees and 
sequencing traces for families 4 and 5. C - Families 6 and 7 do not have variants in either 
MECOM or HOXA11. Unless indicated by a genotype, a DNA sample was unavailable for 
sequencing. Representative sequence traces of both the wild type and the variant are 
shown. RUS – radioulnar synostosis; AA –aplastic anemia; MDS – myelodysplasia; BMF – 
bone marrow failure; M/T – macrocytosis and thrombocytopenia; RUS* - radioulnar 
synostosis is presumed from the clinical description; NAD – no abnormality detected; arrow 
indicates the index case. D - Protein sequence from different species showing the 
conservation of the variants identified in this study (red arrows). The underlined residues 
highlight part of zinc fingers 8 and 9. H.sapiens (human) NP_001098548.2, M.musculus 
(mouse) XP_011247963.1, D.rerio (zebra fish) XP_017206701.1, X.laevis (African clawed 
frog) NP_001089139.1, D.melanogaster (fruit fly) NP_001260545.1, S.cervisiae (yeast) 
KZV08884.1. E - Schematic representation of MECOM encompassing both the MDS1 and 
the EVI1 components of the complex. All germline variants identified to date are mapped on 
to this diagram. Red arrows/text - variants identified in patients with RUS and hematological 
defects. Blue arrows/text – variants in patients with hematological defects but no RUS. (6) – 
total number of different families reported for this variant.  Protein numbering is relative to the 
EVI1 component of the complex only (NP_001098548.2). NLS – Nuclear localisation signal 
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